What's New for BTK Inhibitors in B-Cell Malignancies? A Winter Hematology Conference Update

Dr Woyach discusses new clinical data with BTK inhibitors in both chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/965742?src=mkm_podcast_addon_965742